Anti-kelch-like 12 and anti-hexokinase 1: Novel autoantibodies in primary biliary cirrhosis

Liver International

Volumn 35, Issue 2, 2015, Pages 642-651

  Norman, Gary L ^a   Yang, Chen Yen ^b   Ostendorff, Heather P ^c   Shums, Zakera ^a   Lim, Mark J ^c   Wang, Jinjun ^b   Awad, Amany ^c   Hirschfield, Gideon M ^d   Milkiewicz, Piotr ^e   Bloch, Donald B ^f,k   Rothschild, Kenneth J ^c   Bowlus, Christopher L ^b   Adamopoulos, Iannis E ^g   Leung, Patrick S C ^b   Janssen, Harry J ^h,i   Cheung, Angela C ^h   Coltescu, Catalina ^j   Gershwin, M Eric ^b  

^a INOVA DIAGNOSTICS INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AMBERGEN INC   (United States)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

^f The Center for Immunology and Inflammatory Diseases and the Division of Rheumatology Allergy and Immunology of the General Medical Services   (United States)

^g SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j TORONTO WESTERN HOSPITAL   (Canada)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Diagnostics; Liver; Serology

Indexed keywords

HEXOKINASE 1 ANTIBODY; KELCH LIKE ASSOCIATED PROTEIN 12 ANTIBODY; MITOCHONDRION ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; ANTI-HEXOKINASE 1 ANTIBODY, HUMAN; ANTI-KLHL12 ANTIBODY, HUMAN; AUTOANTIBODY; BIOLOGICAL MARKER; HEXOKINASE; HK1 PROTEIN, HUMAN; KLHL12 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; SENSITIVITY AND SPECIFICITY; BILIARY CIRRHOSIS; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; PROTEIN MICROARRAY;

AUTOANTIBODIES; BIOMARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEXOKINASE; HUMANS; IMMUNOBLOTTING; LIVER CIRRHOSIS, BILIARY; MICROFILAMENT PROTEINS; PROTEIN ARRAY ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 84921519209     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12690     Document Type: Article

References (50)

1. Hirschfield GM, Gershwin ME. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol 2013; 8: 303-30.
2. Bogdanos DP, Gershwin ME. What is new in primary biliary cirrhosis? Dig Dis 2012; 30(Suppl. 1): 20-31.
3. Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000; 31: 1005-13.
4. Poupon RE, Lindor KD, Pares A, et al. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol 2003; 39: 12-6.
5. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-73.
6. Metcalf JV, Mitchison HC, Palmer JM, et al. Natural history of early primary biliary cirrhosis. Lancet 1996; 348: 1399-402.
7. Zhu H, Bilgin M, Bangham R, et al. Global analysis of protein activities using proteome chips. Science 2001; 293: 2101-5.
8. Hudson ME, Pozdnyakova I, Haines K, Mor G, Snyder M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci USA 2007; 104: 17494-9.
9. Hu CJ, Song G, Huang W, et al. Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays. Mol Cel Proteomics 2012; 11: 669-80.
10. Jin L, Pahuja KB, Wickliffe KE, et al. Ubiquitin-dependent regulation of COPII coat size and function. Nature 2012; 482: 495-500.
11. Rondou P, Haegeman G, Vanhoenacker P, Van Craenenbroeck K. BTB Protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligase. J Biol Chem 2008; 283: 11083-96.
12. Funato Y, Terabayashi T, Sakamoto R, et al. Nucleoredoxin sustains Wnt/beta-catenin signaling by retaining a pool of inactive dishevelled protein. Curr Biol 2010; 20: 1945-52.
13. Saraiva LM, Seixas Da Silva GS, Galina A, et al. Amyloid-beta triggers the release of neuronal hexokinase 1 from mitochondria. PLoS ONE 2010; 5: e15230.
14. Robey RB, Hay N. Mitochondrial hexokinases: guardians of the mitochondria. Cell Cycle 2005; 4: 654-8.
15. Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology 2009; 50: 291-308.
16. Leung PS, Wang J, Naiyanetr P, et al. Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. J Autoimmun 2013; 41: 79-86.
17. Moteki S, Leung PS, Coppel RL, et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 1996; 24: 97-103.
18. Leung PS, Manns MP, Coppel RL, Gershwin ME. Detection of Antimitochondrial Autoantibodies in Primary Biliary Cirrhosis and LKM Antibodies in Autoimmune Hepatitis, 6th edn. Washington, DC: ASM Press, 2002.
19. Leung PS, Yang GX, Dhirapong A, et al. Animal models of primary biliary cirrhosis: materials and methods. Methods Mol Biol 2012; 900: 291-316.
20. Milkiewicz P, Buwaneswaran H, Coltescu C, et al. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease. Clin Gastroenterol Hepatol 2009; 7: 1355-60.
21. Gabeta S, Norman GL, Liaskos C, et al. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol 2007; 27: 378-87.
22. Granito A, Yang WH, Muratori L, et al. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am J Gastroenterol 2010; 105: 125-31.
23. Agmon-Levin N, Shapira Y, Selmi C, et al. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun 2010; 34: 55-8.
24. Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet 2011; 377: 1600-9.
25. Nardi N, Brito-Zeron P, Ramos-Casals M, et al. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren's syndrome: prevalence and clinical significance in 335 patients. Clin Rheumatol 2006; 25: 341-6.
26. Skare TL, Nisihara RM, Haider O, Azevedo PM, Utiyama SR. Liver autoantibodies in patients with scleroderma. Clin Rheumatol 2011; 30: 129-32.
27. Leung PS, Rossaro L, Davis PA, et al. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology 2007; 46: 1436-42.
28. Uchida K, Akita Y, Matsuo K, et al. Identification of specific autoantigens in Sjogren's syndrome by SEREX. Immunology 2005; 116: 53-63.
29. Gonzalez-Gronow M, Cuchacovich M, Francos R, et al. Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism. J Neuroimmunol 2010; 227: 153-61.
30. Miyakawa H, Tanaka A, Kikuchi K, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34: 243-8.
31. Bizzaro N, Covini G, Rosina F, et al. Overcoming a 'probable' diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. Clin Rev Allergy Immunol 2012; 42: 288-97.
32. Ruffatti A, Arslan P, Floreani A, et al. Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis. J Clin Immunol 1985; 5: 357-61.
33. Szostecki C, Krippner H, Penner E, Bautz FA. Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin Exp Immunol 1987; 68: 108-16.
34. Copple SS, Martins TB, Masterson C, Joly E, Hill HR. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera. Ann N Y Acad Sci 2007; 1109: 464-72.
35. Rigopoulou EI, Dalekos GN. Molecular diagnostics of primary biliary cirrhosis. Expert Opin Med Diagn 2008; 2: 621-34.
36. Dahnrich C, Pares A, Caballeria L, et al. New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem 2009; 55: 978-85.
37. Copple SS, Sawitzke AD, Wilson AM, Tebo AE, Hill HR. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis. Am J Clin Pathol 2011; 135: 678-84.
38. Nakamura M, Takii Y, Ito M, et al. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis. J Autoimmun 2006; 26: 138-45.
39. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. Increased expression of mitochondrial proteins associated with autophagy in biliary epithelial lesions in primary biliary cirrhosis. Liver Int 2013; 33: 312-20.
40. Naiyanetr P, Butler JD, Meng L, et al. Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity. J Autoimmun 2011; 37: 209-16.
41. Leung PS, Lam K, Kurth MJ, Coppel RL, Gershwin ME. Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis? Trends Mol Med 2012; 18: 577-82.
42. Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V. In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem J 2004; 377(Pt 2): 347-55.
43. Abu-Hamad S, Zaid H, Israelson A, Nahon E, Shoshan-Barmatz V. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding. J Biol Chem 2008; 283: 13482-90.
44. Villinger S, Briones R, Giller K, et al. Functional dynamics in the voltage-dependent anion channel. Proc Natl Acad Sci USA 2010; 107: 22546-51.
45. Ando Y, Yang GX, Kenny TP, et al. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-beta receptor type II mouse. J Autoimmun 2013; 41: 111-9.
46. Hudspeth K, Pontarini E, Tentorio P, et al. The role of natural killer cells in autoimmune liver disease: a comprehensive review. J Autoimmun 2013; 46: 55-65.
47. Kawata K, Yang GX, Ando Y, et al. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFbetaRII mice. Hepatology 2013; 58: 1094-104.
48. Wang L, Sun Y, Zhang Z, et al. CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology 2014; doi: 10.1002/hep.27306 [Epub ahead of print].
49. Zhang J, Zhang W, Leung PS, et al. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology 2014; doi: 10.1002/hep.27313. [Epub ahead of print].
50. Yang CY, Ma X, Tsuneyama K, et al. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology 2014; 59: 1944-53.